E M Frohman

Summary

Affiliation: University of Texas Southwestern Medical Center
Country: USA

Publications

  1. ncbi Vertigo in MS: utility of positional and particle repositioning maneuvers
    E M Frohman
    Departments of Neurology, University of Texas Southwestern Medical Center, Dallas, TX 75235, USA
    Neurology 55:1566-9. 2000
  2. ncbi Ocular contrapulsion in multiple sclerosis: clinical features and pathophysiological mechanisms
    E M Frohman
    Department of Neurology, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, Texas 75235, USA
    J Neurol Neurosurg Psychiatry 70:688-92. 2001
  3. ncbi Autonomic regulation of neuroimmunological responses: implications for multiple sclerosis
    E M Frohman
    Department of Neurology, University of Texas Southwestern Medical Center at Dallas, 75235, USA
    J Clin Immunol 21:61-73. 2001
  4. ncbi MRI characteristics of the MLF in MS patients with chronic internuclear ophthalmoparesis
    E M Frohman
    Department of Neurology, University of Texas Southwestern Medical Center, Dallas 02115, USA
    Neurology 57:762-8. 2001
  5. ncbi Acquired sexual paraphilia in patients with multiple sclerosis
    Elliot M Frohman
    Department of Neurology, The University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Blvd, Dallas, TX 75235, USA
    Arch Neurol 59:1006-10. 2002
  6. ncbi Quantitative oculographic characterisation of internuclear ophthalmoparesis in multiple sclerosis: the versional dysconjugacy index Z score
    E M Frohman
    Department of Neurology, University of Texas Southwestern Medical Center, Dallas, Texas 75235, USA
    J Neurol Neurosurg Psychiatry 73:51-5. 2002
  7. ncbi Benign paroxysmal positioning vertigo in multiple sclerosis: diagnosis, pathophysiology and therapeutic techniques
    E M Frohman
    Department of Neurology, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas 75235, USA
    Mult Scler 9:250-5. 2003
  8. ncbi Retinal architecture predicts pupillary reflex metrics in MS
    A R Salter
    Department of Neurology, University of Texas Southwestern Medical Center at Dallas, Texas, USA
    Mult Scler 15:479-86. 2009
  9. ncbi Cup to disc ratio by optical coherence tomography is abnormal in multiple sclerosis
    S B Syc
    Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    J Neurol Sci 302:19-24. 2011
  10. ncbi Accuracy of clinical detection of INO in MS: corroboration with quantitative infrared oculography
    T C Frohman
    Department of Neurology, University of Texas Southwestern Medical Center at Dallas, TX 75235, USA
    Neurology 61:848-50. 2003

Collaborators

Detail Information

Publications25

  1. ncbi Vertigo in MS: utility of positional and particle repositioning maneuvers
    E M Frohman
    Departments of Neurology, University of Texas Southwestern Medical Center, Dallas, TX 75235, USA
    Neurology 55:1566-9. 2000
    ..All patients diagnosed with benign paroxysmal positioning vertigo were treated successfully with particle repositioning maneuvers...
  2. ncbi Ocular contrapulsion in multiple sclerosis: clinical features and pathophysiological mechanisms
    E M Frohman
    Department of Neurology, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, Texas 75235, USA
    J Neurol Neurosurg Psychiatry 70:688-92. 2001
    ..In conclusion, ocular contrapulsion can be seen in patients with multiple sclerosis and results from a lesion in the region of the SCP, involving the uncinate fasciculus...
  3. ncbi Autonomic regulation of neuroimmunological responses: implications for multiple sclerosis
    E M Frohman
    Department of Neurology, University of Texas Southwestern Medical Center at Dallas, 75235, USA
    J Clin Immunol 21:61-73. 2001
    ..These studies may have relevance for a number of inflammatory conditions in humans, including multiple sclerosis...
  4. ncbi MRI characteristics of the MLF in MS patients with chronic internuclear ophthalmoparesis
    E M Frohman
    Department of Neurology, University of Texas Southwestern Medical Center, Dallas 02115, USA
    Neurology 57:762-8. 2001
    ....
  5. ncbi Acquired sexual paraphilia in patients with multiple sclerosis
    Elliot M Frohman
    Department of Neurology, The University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Blvd, Dallas, TX 75235, USA
    Arch Neurol 59:1006-10. 2002
    ..In contrast, hypersexual behavior and paraphilias are distinctly uncommon in this population of patients, but have been associated with various focal brain lesions...
  6. ncbi Quantitative oculographic characterisation of internuclear ophthalmoparesis in multiple sclerosis: the versional dysconjugacy index Z score
    E M Frohman
    Department of Neurology, University of Texas Southwestern Medical Center, Dallas, Texas 75235, USA
    J Neurol Neurosurg Psychiatry 73:51-5. 2002
    ..There is a poor correlation between multiple sclerosis disease activity, as measured by magnetic resonance imaging, and clinical disability...
  7. ncbi Benign paroxysmal positioning vertigo in multiple sclerosis: diagnosis, pathophysiology and therapeutic techniques
    E M Frohman
    Department of Neurology, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas 75235, USA
    Mult Scler 9:250-5. 2003
    ..To report on the most common causes of vertigo in patients with multiple sclerosis (MS) and emphasize appropriate diagnostic techniques and treatment interventions...
  8. ncbi Retinal architecture predicts pupillary reflex metrics in MS
    A R Salter
    Department of Neurology, University of Texas Southwestern Medical Center at Dallas, Texas, USA
    Mult Scler 15:479-86. 2009
    ..To study the relation of retinal nerve fiber layer thinning to clinical and physiologic measures of visual function in patients with MS or neuromyelitis optica and unilateral optic neuropathy...
  9. ncbi Cup to disc ratio by optical coherence tomography is abnormal in multiple sclerosis
    S B Syc
    Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    J Neurol Sci 302:19-24. 2011
    ..To identify and characterize cup to disc ratio (CDR) and related optic nerve head abnormalities in multiple sclerosis (MS) using spectral domain optical coherence tomography (OCT)...
  10. ncbi Accuracy of clinical detection of INO in MS: corroboration with quantitative infrared oculography
    T C Frohman
    Department of Neurology, University of Texas Southwestern Medical Center at Dallas, TX 75235, USA
    Neurology 61:848-50. 2003
    ..Intermediate dysconjugacy was not detected by 25% of the evaluators. In the most severe cases, INO was not identified by only 6%. Oculographic techniques significantly enhance the precision of INO detection compared to the clinical exam...
  11. ncbi Immunologic, clinical, and radiologic status 14 months after cessation of natalizumab therapy
    O Stuve
    Neurology Section, VA North Texas Health Care System, Medical Service, Dallas, TX 75216, USA
    Neurology 72:396-401. 2009
    ....
  12. ncbi Pearls & Oy-sters: The medial longitudinal fasciculus in ocular motor physiology
    T C Frohman
    Department of Neurology, University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Blvd, Dallas, TX75235, USA
    Neurology 70:e57-67. 2008
    ..To review the role played by the medial longitudinal fasciculus (MLF) in ocular motor physiology and to characterize a number of syndromes that result from lesions in this eloquent brainstem tract system...
  13. ncbi Break in binocular fusion during head turning in MS patients with INO
    D A Mills
    Department of Neurology, University of Texas Southwestern Medical Center at Dallas, Dallas, TX 75390, USA
    Neurology 71:458-60. 2008
  14. ncbi Most patients with multiple sclerosis or a clinically isolated demyelinating syndrome should be treated at the time of diagnosis
    E M Frohman
    Departments of Neurology and Ophthalmology, University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Boulevard, Dallas, TX 75235, USA
    Arch Neurol 63:614-9. 2006
  15. ncbi Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis
    E Gordon Lipkin
    Department of Neurology, Johns Hopkins School of Medicine, Baltimore, MD, USA
    Neurology 69:1603-9. 2007
    ..Optical coherence tomography (OCT) noninvasively quantifies retinal nerve fiber layer (RNFL) thickness. Studies show RNFL thinning in multiple sclerosis (MS), and we assessed its association with brain atrophy...
  16. ncbi A unique antibody gene signature is prevalent in the central nervous system of patients with multiple sclerosis
    A J Ligocki
    Department of Neurology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA
    J Neuroimmunol 226:192-3. 2010
    ..Genetic analysis of B cells isolated from post-mortem CNS tissue samples from four MS brains demonstrated that signature enriched B cells are present at the site of tissue injury as well as in the circulating CSF...
  17. ncbi Characterizing the mechanisms of progression in multiple sclerosis: evidence and new hypotheses for future directions
    E M Frohman
    Department of Neurology, University of Texas Southwestern Medical Center at Dallas, 75235, USA
    Arch Neurol 62:1345-56. 2005
    ....
  18. ncbi Disease modifying agent related skin reactions in multiple sclerosis: prevention, assessment, and management
    E M Frohman
    Department of Neurology, University of Texas Southwestern Medical Center at Dallas, Dallas, TX 75235, USA
    Mult Scler 10:302-7. 2004
    ..However, some reactions can evolve into potentially serious lesions culminating in infection, necrosis, and in some circumstances requiring surgical repair...
  19. ncbi Azathioprine myelosuppression in multiple sclerosis: characterizing thiopurine methyltransferase polymorphisms
    E M Frohman
    Department of Neurology, University of Texas Southwestern Medical Center at Dallas, Dallas, TX 75235, USA
    Mult Scler 12:108-11. 2006
    ..We review the literature concerning this molecular derangement and underscore the importance of performing surveillance testing for allelic characterization prior to treatment intervention with this agent for immune-mediated disorders...
  20. ncbi The utility of MRI in suspected MS: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
    E M Frohman
    University of Texas Southwestern Medical Center at Dallas, USA
    Neurology 61:602-11. 2003
    ..By contrast, normal results on MRI at the time of clinical presentation makes the future development of CDMS considerably less likely...
  21. ncbi Modeling Uhthoff's phenomenon in MS patients with internuclear ophthalmoparesis
    S L Davis
    Institute for Exercise and Environmental Medicine, Presbyterian Hospital of Dallas, TX, USA
    Neurology 70:1098-106. 2008
    ....
  22. ncbi Neutralizing antibodies to interferon beta: assessment of their clinical and radiographic impact: an evidence report: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
    D S Goodin
    University of California, San Francisco, CA, USA
    Neurology 68:977-84. 2007
    ....
  23. ncbi Mechanisms of action of disease-modifying agents and brain volume changes in multiple sclerosis
    R Zivadinov
    Buffalo Neuroimaging Analysis Center, Jacobs Neurological Institute, 100 High Street, Buffalo, NY 14203, USA
    Neurology 71:136-44. 2008
    ..The effects of corticosteroid therapy on changes in BV in patients with MS help clarify the mechanisms through which potent anti-inflammatory treatments may prevent, stabilize, or induce BV loss...
  24. ncbi Disease modifying therapies in multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines
    D S Goodin
    Neurology 58:169-78. 2002
  25. ncbi The use of mitoxantrone (Novantrone) for the treatment of multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
    D S Goodin
    Therapeutics and Technology Assessment Subcommittee, American Academy of Neurology, St. Paul, MN 55116, USA
    Neurology 61:1332-8. 2003
    ....